Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hermans MP et al. – The study demonstrates that nebivolol in mild to moderate hypertension is associated with overall improvements in QoL, with a marked BP–lowering effect, in mono–therapy, add–on or switch, irrespective of the glucose tolerance status. It may be hypothesized that its dual mode of action explains its BP–lowering effect as well as the tolerability

Today in Hypertension...keeping you current

Improved 24-Hour Blood Pressure Control With Sirolimus Versus Calcineurin Inhibitor Based Immunosuppression in Renal Transplant Recipients
Transplantation Proceedings, 12/18/09

Zigzagged Augmentation Index in Diabetes
Clinical and Experimental Hypertension, 12/18/09

Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis
Clinical Reviews in Allergy and Immunology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address